Quantum Healthcare Limited
Quantum Healthcare Limited, together with its subsidiaries, engages in the design, assembly, and distribution of advanced therapeutic solutions for the minimally invasive treatment of complex vascular diseases in Singapore. It operates through Vascular Business, Healthcare Business, Corporate segments. The Vascular Business segment engages in the development, manufacturing, and distribution of me… Read more
Quantum Healthcare Limited (QTHLF) - Net Assets
Latest net assets as of September 2025: $-3.59 Million USD
Based on the latest financial reports, Quantum Healthcare Limited (QTHLF) has net assets worth $-3.59 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($11.11 Million) and total liabilities ($14.70 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-3.59 Million |
| % of Total Assets | -32.33% |
| Annual Growth Rate | N/A |
| 5-Year Change | -398.2% |
| 10-Year Change | N/A |
| Growth Volatility | 134.67 |
Quantum Healthcare Limited - Net Assets Trend (2020–2025)
This chart illustrates how Quantum Healthcare Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Quantum Healthcare Limited (2020–2025)
The table below shows the annual net assets of Quantum Healthcare Limited from 2020 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | $-2.98 Million | +1.75% |
| 2024-06-30 | $-3.03 Million | -86.00% |
| 2023-06-30 | $-1.63 Million | +37.40% |
| 2022-06-30 | $-2.60 Million | -360.66% |
| 2021-06-30 | $997.65K | -91.31% |
| 2020-06-30 | $11.48 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Quantum Healthcare Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 8318300000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $248.28 Million | % |
| Total Equity | $-3.62 Million | 100.00% |
Quantum Healthcare Limited Competitors by Market Cap
The table below lists competitors of Quantum Healthcare Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
METALS CREEK RES
F:M1C1
|
$2.42 Million |
|
CONVERGENZE S.P.A. SB
F:7E0
|
$2.42 Million |
|
F5 NETWORKS
MU:FFV
|
$2.42 Million |
|
Flashaim Inc.
TWO:7551
|
$2.42 Million |
|
Ganges Securities Limited
NSE:GANGESSECU
|
$2.42 Million |
|
CordovaCann Corp
OTCQB:LVRLF
|
$2.42 Million |
|
SIGNATURE RESOURCES NEW
F:3S30
|
$2.41 Million |
|
Applied DB Public Company Limited
BK:ADB
|
$2.41 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Quantum Healthcare Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -3,865,000 to -3,616,000, a change of 249,000.
- Net loss of 2,234,000 reduced equity.
- New share issuances of 800,000 increased equity.
- Other factors increased equity by 1,683,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-2.23 Million | -61.78% |
| Share Issuances | $800.00K | +22.12% |
| Other Changes | $1.68 Million | +46.54% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Quantum Healthcare Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-06-30 | $0.01 | $0.00 | x |
| 2021-06-30 | $0.00 | $0.00 | x |
| 2022-06-30 | $0.00 | $0.00 | x |
| 2023-06-30 | $0.00 | $0.00 | x |
| 2024-06-30 | $0.00 | $0.00 | x |
| 2025-06-30 | $0.00 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Quantum Healthcare Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -17.61%
- • Asset Turnover: 1.01x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-186.35%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | -113.22% | -121.23% | 0.61x | 1.54x | $-14.15 Million |
| 2021 | -1004.91% | -1360.32% | 0.16x | 4.53x | $-10.13 Million |
| 2022 | 0.00% | 0.00% | 0.00x | 0.00x | $-5.05 Million |
| 2023 | 0.00% | -91.17% | 0.63x | 0.00x | $-8.35 Million |
| 2024 | 0.00% | -27.68% | 1.00x | 0.00x | $-3.23 Million |
| 2025 | 0.00% | -17.61% | 1.01x | 0.00x | $-1.87 Million |
Industry Comparison
This section compares Quantum Healthcare Limited's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Quantum Healthcare Limited (QTHLF) | $-3.59 Million | -113.22% | N/A | $2.42 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |